Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

NZ sharemarket dips as big stocks weigh despite KMD gains
Markets

NZ sharemarket dips as big stocks weigh despite KMD gains

The NZ sharemarket closed down, although KMD Brands lifted on a positive result.

Investor days to test gentailer plans for new build and firming
Markets

Investor days to test gentailer plans for new build and firming

Investors want answers on build delays, capital plans and Huntly’s future.

Argosy delivers strong first-half results
Economy

Argosy delivers strong first-half results

Earnings and net tangible asset value per share up. 

Asset Plus' first-half profit lower as Munroe Lane in focus
Economy

Asset Plus' first-half profit lower as Munroe Lane in focus

First-half net tangible assets per share down on the year.